Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05359016 · ClinicalTrials.gov registry record · NA

Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique

A NA study of Cervical Cancer, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
14,600
Enrollment target
1
Study location

NCT05359016 is a NA study of Cervical Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 14,600 participants, above the 469-participant average among 144 other Cervical Cancer trials with a reported enrollment target (3013% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05359016, a NA study of Cervical Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
14,600 participants
Enrollment target
1
Study location

Study Summary

The goal of this operational research study is to develop, implement and test integrated CCS\&PT and voluntary FP service delivery models to evaluate whether integrated service delivery can optimize uptake and health impact of both services. The study objectives and learning questions are listed below, along with key outcomes that will be measured.

Conditions Studied

Interventions

  • BEHAVIORAL HPV testing of women for cervical cancer screening

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 14,600 participants
Start Date 2020-12-22
Est. Completion 2027-02-02
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT05359016

The ClinicalTrials.gov registry entry for NCT05359016 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 14,600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 469-participant average among 144 other Cervical Cancer trials with a reported enrollment target (3013% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 1 intervention - of which HPV testing of women for cervical cancer screening is the first listed.

NCT05359016 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05359016 about?

NCT05359016 is a clinical study titled "Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique". The goal of this operational research study is to develop, implement and test integrated CCS\&PT and voluntary FP service delivery models to evaluate whether integrated service delivery can optimize uptake and health impact of both services. The study objectives and learning questions are listed bel...

What is the current status of trial NCT05359016?

This trial is currently recruiting. It is a NA study. The enrollment target is 14,600 participants. The study started on 2020-12-22. Estimated completion is 2027-02-02.

What conditions does trial NCT05359016 study?

This clinical trial studies the following conditions: Cervical Cancer.

What interventions are being tested in trial NCT05359016?

The interventions under investigation include: HPV testing of women for cervical cancer screening (BEHAVIORAL).

Who is sponsoring clinical trial NCT05359016?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05359016 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cervical Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.